Devices and Diagnostics

Solving the Dry Eye Mystery With Neurolens’ Jeffrey Krall, OD

By Jackie Wengrod | October 4, 2021

PODCAST EPISODE 300

Read More

Revolutionizing Cataract Surgery from Innovation to Commercialization

By Jackie Wengrod | September 22, 2021

PODCAST EPISODE 298

Read More
OIS Summit FDA Approved (2)

Judy Gordon’s Legacy: Helping Firms Navigate a Path to FDA Approval of Transformative Technology

By Keith Croes | September 7, 2021

Judy Gordon, DVM, is not a job-hopper. When Laguna Beach, Calif.-based ClinReg Consulting Services, a company she founded in 1998, announced her retirement in March,…

Read More
Bausch + Lomb

OSD Pipeline Update: Etiology-Specific Treatments for MGD, Demodex Getting Closer

By Conni Bergmann Koury | August 31, 2021

First-in-class drugs are being investigated to treat two etiologies of dry eye disease (DED)—meibomian gland dysfunction (MGD) and Demodex blepharitis—both highly prevalent conditions for which…

Read More

Drug Developers Show Renewed Interest in Ocular Allergies

By Karen Blum | August 24, 2021

The ocular allergy space has seen some renewed interest lately, with Food and Drug Administration approval of Santen Pharmaceutical’s new drug for vernal keratoconjunctivitis (VKC)…

Read More
Pierre Billardon

Leading a Global Leader, with Pierre Billardon

By Jackie Wengrod | August 24, 2021

PODCAST EPISODE 294

Read More
FDA rejected Abicipar

A Year After FDA Rejected Abicipar, AbbVie Gives It Back to Molecular Partners

By Rich Kirkner | August 17, 2021

In the summer of 2020, shortly after the US Food and Drug Administration issued a negative Complete Response Letter to AbbVie and Molecular Partners, rejecting…

Read More

Second Sight Gets a Double-Shot Boost Thanks to PO and NIH installment

By Rich Kirkner | July 13, 2021

Up until a few weeks ago, 2021 had been an up-and-down year for retinal prosthesis maker Second Sight Medical Products, but it recently got a…

Read More

The Myopia Management Market: ‘How Big is Big?’

By Steve Lenier | May 4, 2021

“How big is big?” That was a question that Dwight Akerman, OD, MBA, FAAO, FBCLA, put to a panel of industry insiders at last week’s…

Read More
Emerging Glaucoma Devices See Beyond IOP

Emerging Glaucoma Devices See Beyond IOP

By Heather Johnson | May 27, 2020

The glaucoma space has been dominated by a host of products designed to lower intraocular pressure (IOP) – minimally invasive glaucoma surgery (MIGS) devices and…

Read More
Soft CL slows myopia in children

Soft CL slows myopia in children

By Keith Croes | January 22, 2020

Globally, the myopia market may be worth upwards of $28 billion by 2026, with single prescription corrective lenses holding a significant market share, according to…

Read More
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

By Steve Lenier | September 18, 2019

LensGen CEO Ramgopal Rao says the company has been built around a laser focus on customers’ needs and wants. That led LensGen to identify a…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.